Novel type of immunotherapy used in mouse-model study shows promise for ALS treatment.

Barbara Sperrazza was a dietitian and diabetes educator who had the warmest smile and loved to help people. She lost her ability to read, write, speak and eventually swallow due to frontotemporal dementia.

Chronic neurological diseases — Alzheimer’s disease, Parkinson’s disease, dystonia, ALS (Lou Gehrig’s disease), Huntington’s disease, neuromuscular disease, multiple sclerosis and epilepsy, to mention only a few — afflict millions of Americans worldwide and account for tremendous morbidity and mortality. Furthermore, age is the largest risk factor for many…